My Application Form Status

Check the status of your application form with Angel Broking.
Arq - The Hyper Intelligent Investment Engine By Angel Broking
Future Enterprises standalone net profit rises 615.37% in the June 2016 quarter

Future Enterprises standalone net profit rises 615.37% in the June 2016 quarter

Sep 14,2016

Net profit of Future Enterprises rose 615.37% to Rs 315.48 crore in the quarter ended June 2016 as against Rs 44.10 crore during the previous quarter ended June 2015. Sales declined 67.64% to Rs 921.19 crore in the quarter ended June 2016 as against Rs 2846.84 crore during the previous quarter ended June 2015.

ParticularsQuarter Ended
n++Jun. 2016Jun. 2015% Var.
Sales921.192846.84-68
OPM %24.969.91-
PBDT295.07184.1360
PBT142.3249.92185
NP315.4844.10615

Powered by Capital Market - Live News

Hong Kong Stocks fall, energy shares weigh
Nov 29,2016

The Hong Kong stock market ended lower on Tuesday, 29 November 2016, weighed down by energy shares as oil prices dropped on doubts that producer cartel OPEC would hammer out an output cut this week. Investors risk appetite was also curbed by a lacklustre performance in global equity markets overnight. Wall Street suffered its worst performance in nearly a month, while European stocks also softened, led by a slump in Italian banks as political risk resurfaced in Europe ahead of a referendum in Italy this weekend. But losses were limited ahead of next weeks unveiling of the much-anticipated Shenzhen-Hong Kong Stock Connect, which will offer foreign individual investors access to the tech-heavy Shenzhen market for the first time. Sector performance was mixed, with energy and raw material shares sliding while industrial and utilities gained. The Hang Seng Index ended down 0.41%, or 93.50 points, to 22,737.07 and the Hang Seng China Enterprises index fell 0.3%, or 29.33 points, to 9,846.21. Turnover decreased to HK$68.7 billion from HK$70.6 billion on Monday.

Powered by Capital Market - Live News

China Market attains highest level 11 months
Nov 29,2016

Mainland China stock market extended their bull run for a fourth session on Tuesday, 29 November 2016, closing at the highest level in almost 11 months as investors hopes that speculation curbs on the real estate market will push funds into equities. Investor sentiment also received a boost after Morgan Stanley upgraded their ratings on mainland stock markets. The blue-chip CSI300 index rose 0.82%, to 3,564.04, while the Shanghai Composite Index gained 0.18% to 3,282.92 points. The Shenzhen Composite Index, which tracks stocks on Chinas second exchange, fell 0.77% to 2,110.36. The measure has added 5.9% so far this month.

Powered by Capital Market - Live News

Nikkei falls on profit booking, soft offshore lead
Nov 29,2016

The Japan share market declined for second straight session on Tuesday, 29 November 2016, as investors continued locking gains after the benchmark index hit 11-months high at the end of last week and on tracking negative lead from Wall Street overnight and a pause in the yens recent weakening.. Total 20 out of 33 TSE industry categories on the main section declined, with Insurance, Iron & Steel, Securities & Commodities Futures, and Glass & Ceramics Products being major losers, while Fishery, Agriculture & Forestry, Chemicals, and Foods issues being notable gainers. The benchmark Nikkei 225 index dropped 0.27%, or 49.85 points, to close at 18,307.04, while the broader Topix index of all first-section issues lost 0.07%, or 1.01 points, to 1,468.57.

Powered by Capital Market - Live News

Cadila Healthcare corrects on profit booking
Nov 29,2016

Meanwhile, the BSE Sensex was up 132.61 points, or 0.50%, to 26,482.78.

On BSE, so far 24,000 shares were traded in the counter, compared with average daily volume of 70,800 shares in the past one quarter. The stock hit a high of Rs 414.60 and a low of Rs 399.10 so far during the day. The stock hit a 52-week high of Rs 429.45 on 1 November 2016. The stock hit a 52-week low of Rs 295.50 on 18 January 2016. The stock had outperformed the market over the past 30 days till 28 November 2016, falling 1.86% compared with the 5.66% decline in the Sensex. The scrip had also outperformed the market in past one quarter, rising 6.50% as against Sensexs 7.03% decline.

The large-cap company has equity capital of Rs 102.37 crore. Face value per share is Re 1.

Shares of Cadila Healthcare rose 12.51% in five trading sessions to settle at Rs 411 yesterday, 28 November 2016, from its close of Rs 365.30 on 21 November 2016.

Cadila Healthcares consolidated net profit fell 28.93% to Rs 337.60 crore on 3.08% increase in net sales to Rs 2336.30 crore in Q2 September 2016 over Q2 September 2015.

Cadila Healthcare is a global pharmaceutical company that discovers, manufactures and markets a broad range of healthcare therapies.

Powered by Capital Market - Live News

Rally in Sagar Cements fizzles out on profit booking
Nov 29,2016

Meanwhile, the S&P BSE Sensex was up 114.82 points or 0.44% at 26,464.99.

On the BSE, 8,271 shares were traded on the counter so far as against the average daily volumes of 4,956 shares in the past one quarter. The stock had hit a high of Rs 724 and a low of Rs 692.45 so far during the day. The stock had hit a record high of Rs 835 on 14 October 2016. The stock had hit a 52-week low of Rs 350 on 18 February 2016. The stock had outperformed the market over the past one month till 28 November 2016, sliding 2.02% compared with the Sensexs 5.7% fall. The scrip had also outperformed the market in past one quarter, advancing 9.82% as against the Sensexs 5.15% fall.

The small-cap company has equity capital of Rs 17.39 crore. Face value per share is Rs 10.

Shares of Sagar Cements rallied 20.5% in the preceding five trading sessions to settle at Rs 714.05 yesterday, 28 November 2016, from its close of Rs 592.80 on 21 November 2016. Lions part of the rally materialized in a single trading session yesterday, 28 November 2016, when the stock settled higher by 15.19%, after the companys board at a meeting held on 28 November 2016, fixed an issue price of Rs 800 per equity share for the proposed issue of 6.11 lakh equity shares of the company on preferential basis, subject to requisite approvals. The issue price is at a premium of 15.04% over ruling market price.

Net profit of Sagar Cements declined 71.53% to Rs 2.50 crore on 29% decline in net sales to Rs 119.20 crore in Q2 September 2016 over Q2 September 2015.

Sagar Cements is engaged in manufacturing of cement.

Powered by Capital Market - Live News

Bajaj Hindusthan Sugar gets revision in ratings for bank facilities
Nov 29,2016

Bajaj Hindusthan Sugar has received revision in credit ratings from Credit Analysis & Research for the Companys bank facilities -

Long term bank facilities (Rs 8780.58 crore) - CARE BB+ (Revised from CARE BB)

Short term bank facilities (Rs 329.04 crore) - CARE A4+ (Revised from CARE A4)

Powered by Capital Market - Live News

Cash Flow Recovery Concern for Corporates with Relatively Weak Asset Quality
Nov 29,2016

India Ratings and Research (Ind-Ra) says that 111 of the top 500 corporate borrowers, which held INR7.4trn of the overall debt of INR30.2trn at FYE16, are unlikely to generate higher return on capital employed (ROCE) than weighted average cost of capital (WACC), even in a high economic growth scenario. The agency attributed this to an incremental build-up of relatively high non-productive assets during FY11-FY16. Such corporates witnessed a decline in the proportion of their fixed assets to total assets to 52% in FY16 from 71% in FY11. As a result, the credit metrics of these corporates are likely to marginally improve in the near term.

85 Corporates with Relatively Weak Asset Quality Unlikely to ReviveInd-Ra analysed the balance sheets of borrowers for the period FY11-FY16. The agency observed that INR4trn of the INR12.4trn debt as at FYE16 of the 240 Vulnerable corporates was held by entities with a relatively high proportion of non-productive assets and weak cash flows. Debt servicing could remain a challenge for such corporates. Hence, these entities must engage in deep debt restructurings and reduce their debt significantly for long-term sustainability. Banks exposed to such entities may find it difficult to fit these corporates into the Scheme for Sustainable Structuring of Stressed Assets (S4A). Largely, corporates from infrastructure and construction, sugar, consumer durables, engineering and equipment, airlines and trading have a relatively high proportion of non-productive assets and a structural mismatch in cash flows.

155 Corporates with Relatively Better Asset Quality to Gain from Economic Recovery

Ind-Ra believes that corporates with a relatively high proportion of productive assets but with cash flow mismatches have a better chance of servicing their debts. Such corporates accounted for INR8.4trn debt of the overall Vulnerable debt. Ind-Ra believes such corporates could fall under the ambit of S4A scheme. Although haircuts may still be inevitable in many of them, quantum could be significantly lower. Such entities are likely to generate higher ROCE than WACC as the economy recovers. With an economic recovery, sectors such as oil and gas, metals and mining, power and textile are likely to rebound.

26 Corporates with Relatively Weak Asset Quality to Continue to Receive Lender Support

Ind-Ra expects lower shareholder returns to be generated by 26 Non-Vulnerable corporates with low volatility in cash flows but a relatively high proportion of non-productive assets. These entities accounted for INR3.4trn of the INR17.8trn debt held by Non-Vulnerable corporates. The debt servicing ability of these corporates would remain intact, as many of them benefit from strong parentage. Ind-Ra believes equity investment would be the most desirable option for these entities to deleverage and improve their capital structure. Sectors such as real estate and telecom have corporates with a relatively high proportion of non-productive assets and low, but, positive cash flow growth.

234 Corporates with Relatively Better Asset Quality to Drive Private Sector Capex

Corporates with strong profitability levels, healthy capital structures and a relatively higher productive asset base hold INR14.3trn debt of the overall Non-Vulnerable debt. These entities are likely to significantly benefit from an economic recovery. Ind-Ra believes these corporates would be the key driver of a revival in private sector investment. Corporates from sectors such as auto and automotive supplier, cement, chemical and pharmaceutical have low cash flow volatility and a high proportion of productive assets.

Powered by Capital Market - Live News

Outcome of board meeting of Gokul Refoils and Solvent
Nov 29,2016

Gokul Refoils and Solvent announced that at the meeting of Board of Directors held on 29 November 2016, the following matters have been approved:-

1. To evaluate the option of divestment of Haldia Undertaking of the Company and obtain prior approval of the members of the Company for said divestment pursuant to Section 180(1)(a) of the Companies Act, 2013.

2. Postal Ballot Notice and Postal Ballot Form

3. Calendar of Events for the Postal Ballot Process.

Powered by Capital Market - Live News

Exide Industries director resigns
Nov 29,2016

Exide Industries announced that Nadeem Kazim, Director - HR & Personnel of the Company has tendered his resignation with effect from the close of business hours on 28 November 2016 due to personal reasons.

Powered by Capital Market - Live News

Natco Pharma receives ANDA approval for Generic Armodafinil Tablets
Nov 29,2016

Natco Pharma has received final approval for Abbreviated New Drug Application (ANDA) containing a paragraph IV certification filed with the United Food and Drug Administration for generic version of Armodafinil Tablets, 50 mg, 150 mg and 250 mg. The Company and its marketing partner Breckenridge Pharmaceutical, Inc. plant to launch this product in USA market immediately.

Powered by Capital Market - Live News

Tara Jewels to announce September quarter and half year results
Nov 29,2016

Tara Jewels announced that a meeting of the Board of Directors of the Company is scheduled to be held on 09 December 2016, inter alia, to consider and approve the Un-audited Financial Results of the Company for the Quarter and half year ended 30 September 2016

Powered by Capital Market - Live News

Nagarjuna Fertilizers & Chemicals intimates of arbitration awards against itself
Nov 29,2016

Nagarjuna Fertilizers & Chemicals announced that Arbitration Awards have been passed against the Company for the following amounts:

1. Payment of USD 18,40,000 + interest at 5% pa w.e.f 12 September 2013

2. (a) Cost for Interim Final Award - GBP 465,630 + US$ 43,187.79 with interest at 1% above Bank Rate with 3 monthly rests wef 07 January 2016 + GBP 15,000

(b) Cost ordered by the Court at London - GBP 100,000

(c) Second Interim Final Award for a sum of USD 1,43,55,000

The Company is taking necessary steps to contest in relation to the Awards.

Powered by Capital Market - Live News

Board of Medinova Diagnostic Services approves preferential issue of shares
Nov 29,2016

The Board of Directors of Medinova Diagnostic Services at its meeting held on 29 November 2016 has approved the issue of 5 lakh equity shares to Vijaya Diagnostic Centre, the Promoter on preferential basis.

Powered by Capital Market - Live News

Promoter of Mac Charles (India) sells shares
Nov 29,2016

Mac Charles (India) announced that the promoter of the Company C.B. Pardhanani has sold 67,43,152 equity shares of Mac Charles (India) at Rs.641.80 each on 28 November 2016 through Block deal on BSE stock exchange.

Powered by Capital Market - Live News

Mac Charles (India) announces sale of shares by promoter
Nov 29,2016

Mac Charles (India) announced that the promoter of the Company C.B. Pardhanani has sold 28,73,800 equity shares of Mac Charles (India)at Rs.642.55 each on 29 November 2016 through Block deal on BSE stock exchange.

Powered by Capital Market - Live News